Sponsor or institution
Clinical trials and research at Johnson & Johnson Enterprise Innovation Inc.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Johnson & Johnson Enterprise Innovation Inc. that are recruiting, at sites in 31 countries (most in United States (5), France (4), Spain (4)). By phase: Phase 1 (3), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 31Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| JNJ-1761981 in solid tumors | Phase 1 | Jacksonville, Florida and 3 other locations | Recruiting | Apr 13, 2026 |
| Intratumoral JNJ-90301900 combined with chemoradiation for locally advanced head and neck squamous cell carcinoma | Phase 1 | Birmingham, Alabama and 24 other locations | Recruiting | Oct 21, 2025 |
| Combining JNJ-90301900 with chemotherapy and radiation for advanced lung cancer | Phase 2 | La Jolla, California and 44 other locations | Recruiting | Oct 31, 2024 |
| Testing JNJ-87704916 for advanced solid tumors | Phase 1 | New York, New York and 9 other locations | Recruiting | Mar 15, 2024 |
| Treatment for elderly patients with advanced head and neck cancer using a new drug and radiation | Phase 3 | Birmingham, Alabama and 195 other locations | Recruiting | May 19, 2021 |
All recruiting trials (5)
-
JNJ-1761981 in solid tumors
A early-phase study tests how safe and tolerable a single intratumor injection of JNJ-1761981 is, and how to best dose it, in adults with solid tumors that have progressed after standard treatment.
-
Intratumoral JNJ-90301900 combined with chemoradiation for locally advanced head and neck squamous cell carcinoma
This phase 1b test will try injecting JNJ-90301900 directly into tumors alongside standard cisplatin chemotherapy and radiation to see if it is safe and helps people with locally advanced head and neck squamous cell carcinoma.
-
Combining JNJ-90301900 with chemotherapy and radiation for advanced lung cancer
This study is testing if adding a new drug called JNJ-90301900 to standard chemotherapy and radiation can help people with advanced lung cancer respond better to treatment.
-
Testing JNJ-87704916 for advanced solid tumors
This study is testing a new treatment called JNJ-87704916, alone and with another drug, to see if it can help people with advanced solid tumors feel better and improve their health.
-
Treatment for elderly patients with advanced head and neck cancer using a new drug and radiation
This study is testing a new drug combined with radiation to see if it helps elderly patients with advanced head and neck cancer feel better compared to just radiation or radiation with another drug.
Quick answers
How many clinical trials run by Johnson & Johnson Enterprise Innovation Inc. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 31 countries. The most sites are in United States (5 trials), France (4 trials), Spain (4 trials), Japan (2 trials), Brazil (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.